ACE and chronic kidney disease: In the non-CKD population with congestive heart failure (CHF), evidence from randomized trials suggests that treatment with certain medications including ACE inhibitors, angiotensin receptor blockers and β-blockers reduces morbidity and mortality in congestive heart failure (CHF).